Clearance Summary
COULTER ACT 5DIFF AL HEMATOLOGY ANALYZER received FDA 510(k) clearance under submission number K032013, sponsored by Beckman Coulter, Inc.. The device was reviewed via the Special premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 2003-07-24.
- Submission: K032013
- Applicant / Sponsor: Beckman Coulter, Inc.
- Clearance pathway: Special
- Review panel: Hematology
- Device class: Class II
- Regulation citation: 21 CFR 864.5220
- Decision date: 2003-07-24
Classification & Regulation
This clearance is catalogued under FDA product code GKZ and 21 CFR 864.5220, within the Hematology review panel as a Class II device.